Authors
Emanuele Bobbio, Sabrina Montuoro, Vera Fico, Emanuele Monda, Mario Merone, Leandro Pecchia, Giuseppe Limongelli
Published in
Heart failure clinics. Volume 23. Issue 1. Pages 67-79. Epub Oct 23, 2026.
Abstract
This article examines the evolving role of artificial intelligence (AI) across the continuum of care in cardiomyopathies, from opportunistic screening to decision-critical risk stratification. AI-enhanced electrocardiography enables scalable early detection, while advanced echocardiographic and cardiac magnetic resonance-based radiomics refine myocardial substrate characterization. Multimodal models integrating imaging, electrical, and clinical data refine risk stratification beyond conventional metrics such as left ventricular ejection fraction. However, clinical translation requires external validation, calibration stability, interpretability, and structured workflow integration. AI emerges not as autonomous diagnosis, but as accountable, clinician-supervised decision support embedded within multidisciplinary cardiovascular care.
PMID:
43039586
Bibliographic data and abstract were imported from PubMed on 17 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 6
- Comments 0